CD33 and breast cancer: Yu et al. identified an “immature” subset of MDSCs (CD33+CD13+CD14−CD15−), induced from CD33+ progenitors upon coculture with the human breast cancer cell line MDA-MB-231, that produced high levels of IDO (172, 173).